8-K
filed January 12, 2026, 6:59 PM ET
ticker MGX
CIK 0001785279
other material
confidence high
sentiment positive
materiality 0.60
Metagenomi renames to Metagenomi Therapeutics; hemophilia A program on track for IND in 2026
Metagenomi Therapeutics, Inc.
- Name changed to Metagenomi Therapeutics, Inc. effective Jan 12, 2026; ticker MGX unchanged.
- Lead program MGX-001: pre-IND meeting completed; IND/CTA on track for Q4 2026.
- Preclinical data showed curative FVIII activity in NHPs with no off-target editing.
- Cash runway extended to Q4 2027 following strategic pipeline prioritization.
- Jian Irish appointed CEO as part of strategic evolution toward in vivo gene editing.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-009928
- form_type
- 8-K
- ticker
- MGX
- cik
- 0001785279
- company_name
- Metagenomi Therapeutics, Inc.
- filed_at
- 2026-01-12T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.169514+00:00
- generated_at
- 2026-05-16T10:55:05.641210+00:00
- sec_items
- ["5.03", "7.01", "9.01"]
- event_type
- other_material
- sentiment
- positive
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-009928
- json_url
- https://secwatch.observer/filing/0001193125-26-009928.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-009928.md
- text_url
- https://secwatch.observer/filing/0001193125-26-009928.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/mgx-20260112.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
WAMFF
Alaska Silver simplifies capital structure, eliminates dual-class shares
Alaska Silver Corp.
May 7, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.
Comparable filing
On May 6, 2026, the Board of Directors of Alaska Silver Corp. (the "Company"), approved an amendment (the "Amendment") to the Company's Articles of the Company to eliminate its dual-class share structure by (i) eliminating its proportionate voting share class and (ii) reidentifying its subordinate voting share class as the class of "Common Shares," no par value, of which the Company shall be authorized to issue an unlimited number of Common Shares.
Filing page
SEC filing
CUK
Carnival completes DLC unification and redomiciliation to Bermuda; Carnival plc now a subsidiary
CARNIVAL PLC
May 7, 2026, 7:59 PM ET
other_material
Items 1.02, 2.01, 3.01, 3.02, 3.03, 5.01, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.
Comparable filing
In addition, Carnival Corporation also migrated its jurisdiction of incorporation from the Republic of Panama to Bermuda and changed its name to "Carnival Corporation Ltd." (the "Redomiciliation" and, together with the DLC Unification, the "DLC Unification and Redomiciliation Transactions").
Filing page
SEC filing
ENZN
Viskase Holdings adopts Section 382 Rights Plan to protect NOL assets; threshold at 4.9%
Viskase Holdings, Inc.
May 5, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.
Comparable filing
In connection with the adoption of the Section 382 Rights Agreement, the Board approved a Certificate of Designation of Series A-2 Junior Participating Preferred Stock of Viskase Holdings, Inc. (the “Certificate of Designation”). The Certificate of Designation was filed with the Secretary of the State of Delaware on May 5, 2026.
Filing page
SEC filing
MTNE
CH4 Natural Solutions Corporation prices $200M IPO; begins trading on NYSE
CH4 Natural Solutions Corp
May 5, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 7.01, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.
Comparable filing
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company’s Amended and Restated Memorandum and Articles of Association (as so amended, the “ Memorandum and Articles ”) were approved on April 30, 2026.
Filing page
SEC filing
INHD
Inno Holdings to effect 1-for-20 reverse stock split on May 4, 2026 for Nasdaq compliance
INNO HOLDINGS INC.
May 4, 2026, 7:59 PM ET
other_material
Items 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.
Comparable filing
On April 30, 2026, Inno Holdings Inc., a Texas holding company (the “Company”) filed a Certificate of Amendment to the Certificate of Formations of the Company with the Secretary of State of the State of Texas (the “Certificate of Amendment”) that provides for a 1-for-20 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding shares of common stock, with no par value (the “Common Stock”).
Filing page
SEC filing
QXL
Viewbix renamed Quantum X Labs Inc.; Nasdaq ticker changes to QXL
Viewbix Inc.
April 30, 2026, 7:59 PM ET
other_material
Items 5.03, 7.01, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.
Comparable filing
effective April 30, 2026, the Company amended and restated its Amended and Restated Bylaws (the "Bylaws") to reflect the Name Change (the "A&R Bylaws"). The A&R Bylaws contain no other changes.
Filing page
SEC filing
IOT
Samsara Inc. reincorporates from Delaware to Nevada, effective June 1, 2026
Samsara Inc.
June 1, 2026, 4:07 PM ET
other_material
Items 3.03, 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.
Comparable filing
the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Reincorporation”) became effective on June 1, 2026, at 12:02 a.m. Pacific Time
Filing page
SEC filing
DCOM
Dime Commercial Bancshares name change effective; three executives amend employment agreements
Dime Community Bancshares, Inc. /NY/
June 1, 2026, 4:02 PM ET
other_material
Items 5.02, 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.
Comparable filing
On May 28, 2026, the Company filed with the Department of State of the State of New York a Certificate of Amendment to Certificate of Incorporation to change our corporate name from Dime Community Bancshares, Inc. to Dime Commercial Bancshares, Inc., effective immediate.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.